Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03328825
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
APT![]() | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.73 | ![]() |
L37![]() | A,B | 1DIG | 0.74 | ![]() | |
FE1![]() | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.7 | ![]() |
PT1![]() | PTEROIC ACID | A,B | 1TX0 | 0.75 | ![]() |
PT1![]() | PTEROIC ACID | A | 1BR6 | 0.75 | ![]() |
PT1![]() | PTEROIC ACID | A,B | 1HWP | 0.75 | ![]() |
354![]() | N-[(S)-(4-{[(2-AMINO-4-HYDROXYQUINAZOLIN- 6-YL)(DIHYDROXY)-LAMBDA~4~-SULFANYL]AMINO}PHENYL)(HYDROXY)METHYL]- L-GLUTAMIC ACID | A,B | 1P4R | 0.72 | ![]() |
ST8![]() | 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)- 5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE | A,B,C,D | 1OGU | 0.7 | ![]() |
DQU![]() | 2,6-DIAMINO-3H-QUINAZOLIN-4-ONE | A | 1R5Y | 0.74 | ![]() |
DQU![]() | 2,6-DIAMINO-3H-QUINAZOLIN-4-ONE | A | 1Q4W | 0.74 | ![]() |
VX1![]() | 4-[3-(4-chlorophenyl)-2,1-benzisoxazol- 5-yl]pyrimidin-2-amine | A | 3BGP | 0.72 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYN | 0.71 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A,B | 2QYK | 0.71 | ![]() |
NPV![]() | 4-[8-(3-nitrophenyl)-1,7-naphthyridin- 6-yl]benzoic acid | A | 2QYL | 0.71 | ![]() |
3B9![]() | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BAC | 0.73 | ![]() |
3B9![]() | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BA9 | 0.73 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.7 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.7 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.7 | ![]() |
T12![]() | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]- 1H-BENZIMIDAZOL-5-YL PIVALATE | A,B,C,D | 2NRU | 0.7 | ![]() |
48B![]() | 2-chloro-N-[4-({5-fluoro-2-[(4- hydroxyphenyl)amino]pyrimidin-4- yl}amino)phenyl]benzamide | A | 3H0Y | 0.72 | ![]() |
THH![]() | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 3DCJ | 0.76 | ![]() |
THH![]() | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 1WSV | 0.76 | ![]() |
L34![]() | 4-(7-AMINO-9-HYDROXY-1-OXO-3,3A,4,5- TETRAHYDRO-2,5,6,8,9B-PENTAAZA- CYCLOPENTA[A]NAPHTHALEN-2-YL)-PHENYLCARBONYL- GLUTAMIC ACID | A,B | 1DIB | 0.74 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DRB | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B,C,D | 2C7V | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1U70 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B,C,D | 1MXF | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 2QK8 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1RB3 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DHJ | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3DAU | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1U72 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 2DRC | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1D1G | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DDR | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1E7W | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1RX3 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3DFR | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B,C,D | 1P33 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3DAT | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DHI | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1TDR | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DRA | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3EIG | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3CD2 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1AO8 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1DF7 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1DLS | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1RG7 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1RH3 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 4DFR | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1RA3 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1DDS | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 1DRE | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 1AXW | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A | 3CL9 | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B | 3DRC | 0.71 | ![]() |
MTX![]() | METHOTREXATE | A,B,C,D,E | 2OIP | 0.71 | ![]() |
826![]() | 1,3,4,9-TETRAHYDRO-2-(HYDROXYBENZOYL)- 9-[(4-HYDROXYPHENYL)METHYL]-6-METHOXY- 2H-PYRIDO[3,4-B]INDOLE | A,B | 1I30 | 0.71 | ![]() |
138![]() | A,B,C,D | 1JKX | 0.74 | ![]() | |
NHR![]() | 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN- 6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}- PENTANEDIOIC ACID | A,B | 1C3E | 0.81 | ![]() |
PSB![]() | 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-N-[2-(2-(HYDROXYMETHYL- PHENYLSULFANYL)-BENZYL]-BENZAMIDE | A | 1RSD | 0.71 | ![]() |
859![]() | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.75 | ![]() |
G6G![]() | N-{3-[(3-{4-[(4-methoxyphenyl)amino]- 1,3,5-triazin-2-yl}pyridin-2-yl)amino]- 4-methylphenyl}-4-[(4-methylpiperazin- 1-yl)methyl]benzamide | A,B | 3G6G | 0.71 | ![]() |
447![]() | N-(4-{[6-methoxy-7-(3-morpholin- 4-ylpropoxy)quinazolin-4-yl]amino}phenyl)benzamide | A,B | 2VRX | 0.71 | ![]() |
L24![]() | [[[2-AMINO-5,6,7,8-TETRAHYDRO-4- HYDROXY-PYRIDO[2,3-D]PYRIMIDIN- 6-YL]-ETHYL]-PHENYL]-CARBONYL-GLUTAMIC ACID | A,B | 1DIA | 0.72 | ![]() |
CL4![]() | N-{3-[5-(6-AMINO-PURIN-9-YL)-3,4- DIHYDROXY-TETRAHYDRO-FURAN-2-YL]- ALLYL}-2,3-DIHYDROXY-5-NITRO-BENZAMIDE | A | 1JR4 | 0.7 | ![]() |
COP![]() | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.74 | ![]() |
COP![]() | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.74 | ![]() |
COG![]() | 2,4-DIAMINO-6-[N-(2',5'-DIMETHOXYBENZYL)- N-METHYLAMINO]QUINAZOLINE | A | 1LY3 | 0.7 | ![]() |
N1H![]() | H | 2F9B | 0.7 | ![]() | |
P40![]() | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.7 | ![]() |
Q22![]() | (4aS)-5-[(2,4-diaminopteridin-6- yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin- 8-ol | A | 3D80 | 0.7 | ![]() |